ArticleJournal of blood medicine2026

Comparative Outcomes of Generic and Branded Dasatinib in Chronic-Phase Chronic Myeloid Leukemia: A Single-Center Within-Patient Analysis.

Anas Babiker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.